Literature DB >> 6446395

Microbiological studies on cefoperazone.

F H Kayser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6446395

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


× No keyword cloud information.
  9 in total

1.  Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.

Authors:  B Kemmerich; H Lode; G Belmega; T Jendroschek; K Borner; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

2.  The in vitro activity of N-formimidoyl thienamycin compared with other broad-spectrum cephalosporins and with clindamycin and metronidazole.

Authors:  G Tischhauser; F H Kayser
Journal:  Infection       Date:  1983 Jul-Aug       Impact factor: 3.553

3.  Cefoperazone pharmacokinetics in preterm infants.

Authors:  J A Bosso; G M Chan; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

4.  Concentrations of cefoperazone in cerebrospinal fluid during bacterial meningitis.

Authors:  D Cable; G Overturf; G Edralin
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

5.  Cefoperazone therapy of bacterial meningitis: a clinical trial.

Authors:  P Cristiano; R Pempinello; M R Iovene; L Coppola; P Altucci
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

Review 6.  Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

7.  Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.

Authors:  R N Jones; T L Gavan; A L Barry; C Thornsberry; D L Gibbs
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

8.  Cefoperazone in lower respiratory tract infections.

Authors:  C J Woods; R B Ellis-Pegler
Journal:  Drugs       Date:  1981       Impact factor: 9.546

Review 9.  Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; A Carmine; R C Heel; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-12       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.